Dear Friends, It is a great pleasure to know that now Virorav has also come out with the intradermal option (attachment). This will be a further boost to the intradermal ARV campaign in India to controll rabies. After Rabipur, Abhyrab and Indirav, this will be the fourth drug offering a low-cost intradermal option in India. Regards,
Dr. Omesh BhartiM.B.B.S., D.H.M., M.A.E. (Epidemiology)Directorate of Health Safety and Regulation,
Himachal Pradesh+91-9418120302[[email protected]][email protected][/email]; [email protected]
Dear Sir,
Please correct the name Indirav to INDIRAB which is thecorrect brandname of the rabies vaccine manufactured by us. Thank you.
Regards,
Dr.G.V.J.A.Harshavardhan
Director - RVDP
Genome Valley, Shameerpet, Hyderabad - 500 078. A.P. India.
Tel.: +91 40 2348 0567 Fax: +91 40 2348 0560 www.bharatbiotech.com
Dear Sir, Thanks for pointing out this mistake, actually it was a slip of finger as V and B are side by side on the typing board. Thanks
Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology)Directorate of Health Safety and Regulation,
Himachal Pradesh+91-9418120302[[email protected]][email protected][/email]; [email protected]
- Page :
- 1
There are no replies made for this post yet.